Clinical Trials
5 trialsNCT03786094 2023-11-01
FORTRESS
Spexis AG
Phase 3 Terminated
NCT04826016 2023-03-20
POLTER
MedSIR
Phase 1/2 Withdrawn
NCT01837095 2018-09-14
Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer
Polyphor Ltd.
Phase 1 Completed
NCT01413568 2016-02-26
Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies
Polyphor Ltd.
Phase 1/2 Completed
NCT01105403 2014-04-23
Exploratory Study on POL6326 in Stem Cell Mobilization
Polyphor Ltd.
Phase 2 Completed